Abstract:Background: Hydration remains the cornerstone prevention of contrast-induced acute kidney injury among high risk patients. However, there is great conflict between long-term preprocedural hydration and shortest door-to-balloon time among patients with ST-elevation myocardial infarction. We aimed to determine the effects of aggressive and targeted hydration on contrast-induced acute kidney injury in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Methods: We did this open-label, randomized controlled trial at 15 teaching hospitals in China. Patients who undergoing primary percutaneous coronary intervention at high risk for contrast-induced acute kidney injury were randomized (1:1) to receive aggressive hydration (preprocedural loading dose of 125/250 mL normal saline within 30 minutes, followed by postprocedural hydration guided by left ventricular end-diastolic pressure for 4 hours and additional hydration until 24 hours after primary percutaneous coronary intervention) or general hydration (≤500 mL normal saline from randomization until 6 hours after primary percutaneous coronary intervention). The primary endpoint is contrast-induced acute kidney injury, defined as a >25% or 0.5 mg/dL increase in serum creatinine from baseline during the first 48-72 hours after primary angioplasty. Postprocedural acute heart failure is the safety endpoint. This trial is registered with ClinicalTrials.gov number, NCT02067195.Findings: Between July 2014 and May 2018, we enrolled 560 patients, of whom 488 patients (mean age 60.1 years, 414 [84.8%] male) were analysed after excluding 72 patients, and 19 patients were not included in primary endpoint analysis for lacking periprocedural serum creatinine data. Contrast-induced acute kidney injury occurred in 51 of 234 patients (21.8%) in the aggressive hydration group and 73 of 235 patients (31.1%) in the control group. The absolute difference (Aggressive hydration vs general hydration) was -11.9% (95% CI -9.4% to -15.0%). Postprocedural acute heart failure did not differ significantly between the aggressive hydration group and the control group (7.9% vs. 6.9%, P=0.69). Interpretation: In high-risk patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention, aggressive hydration reduced the risk of contrast-induced acute kidney injury and was generally well tolerated, with no significantly increase in postprocedural acute heart failure. Aggressive and targeted hydration could be a new treatment strategy for patients with ST-elevation myocardial infarction. Trial Registration Number: This trial is registered with ClinicalTrials.gov number, NCT02067195. Funding Information: National Science Foundation of China, Beijing Lisheng Cardiovascular Health Foundation and Guangdong Provincial People's Hospital Foundation.Declaration of Interests: Authors declared no competing interests.Ethical Approval: The study was approved by Guangdong Provincial People's Hospital institutional review board and regulatory authorities at sites not overseen by Guangdong Provincial People's Hospital.

Left ventricular end-diastolic pressure-guided hydration for the prevention of contrast-induced acute kidney injury in patients with stable ischemic heart disease: the LAKESIDE trial

A new hydration strategy can reduce contrast-induced acute kidney injury after PCI in patients with chronic heart failure and chronic kidney disease: a two-center randomized controlled trial

Aggressive Hydration and Contrast-Induced Acute Kidney Injury Following Primary Angioplasty (ATTEMPT): A Prospective, Randomised , Open-Label Trial

Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial

Association of the Classification and Severity of Heart Failure with the Incidence of Contrast-Induced Acute Kidney Injury

Renal insufficiency following contrast media administration trial III: Urine flow rate‐guided versus left‐ventricular end‐diastolic pressure‐guided hydration in high‐risk patients for contrast‐induced acute kidney injury. Rationale and design

Length of Preprocedure Fasting Was Associated With Contrast Associated-Acute Kidney Injury in High-Risk Patients Undergoing Coronary Angiography

Abstract 13780: Aggressive Hydration and Contrast-Induced Acute Kidney Injury Following Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction: A Randomized Controlled Study

Simplified Rapid Hydration Prevents Contrast-Associated Acute Kidney Injury Among CKD Patients Undergoing Coronary Angiography

Clinical Outcomes of Contrast-Induced Nephropathy in Patients Undergoing Percutaneous Coronary Intervention: A Prospective, Multicenter, Randomized Study to Analyze the Effect of Hydration and Acetylcysteine

Combined strategy of device‐based contrast minimization and urine flow rate‐guided hydration to prevent acute kidney injury in high‐risk patients undergoing coronary interventional procedures

Simplified rapid hydration and contrast-associated acute kidney injury among CKD patients stratified by Mehran score: sub-analysis from the TIME Trial

Efficacy of post-procedural oral hydration volume on risk of contrast-induced acute kidney injury following primary percutaneous coronary intervention: study protocol for a randomized controlled trial

Prevention of Contrast-Induced Acute Kidney Injury: an Update

The Role of Saline and Sodium Bicarbonate Preprocedural Hydration to Prevent Mid-term Renal Insufficiency in Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention

Prevention of postcontrast acute kidney injury after percutaneous transluminal angioplasty by inducing RenalGuard controlled furosemide forced diuresis with matched hydration: study protocol for a randomised controlled trial

Remedial Hydration Reduces the Incidence of Contrast-Induced Nephropathy and Short-Term Adverse Events in Patients with ST-segment Elevation Myocardial Infarction: a Single-Center, Randomized Trial.

Prevention of contrast-induced acute kidney injury in patients undergoing cardiovascular procedures-a systematic review and network meta-analysis

Effect of Vigileo/FloTrac System-Guided Aggressive Hydration in Acute Myocardial Infarction Patients to Prevent Contrast-Induced Nephropathy After Urgent Percutaneous Coronary Intervention

Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease

Kidney protection strategy lowers the risk of contrast-associated acute kidney injury